메뉴 건너뛰기




Volumn 3, Issue 4, 2011, Pages 3555-3568

Antigenic site detection of the spike protein and designing of a vaccine candidate against sars coronavirus using reverse vaccinology: An in silico approach

Author keywords

Reverse vaccinology; Spike protein; T cell epitope; Vaccine design

Indexed keywords

EPITOPE; NEUTRALIZING ANTIBODY; SINGLE STRANDED RNA; T LYMPHOCYTE RECEPTOR; VIRUS DNA; VIRUS PROTEIN; VITRONECTIN;

EID: 84555202346     PISSN: None     EISSN: 0975766X     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (14)
  • 1
    • 0242458317 scopus 로고    scopus 로고
    • Assessment of Putative Protein Targets Derived from the SARS Genome
    • Understanding the SARS Genome/Proteome Using DS Gene, DS GeneAtlas, and DS AtlasStore Publication by Lisa Yan, Mikhail Velikanov, Paul Flook, Wenjin Zheng, Sándor Szalma, and Scott Kahn
    • Understanding the SARS Genome/Proteome Using DS Gene, DS GeneAtlas, and DS AtlasStore Publication by Lisa Yan, Mikhail Velikanov, Paul Flook, Wenjin Zheng, Sándor Szalma, and Scott Kahn, "Assessment of Putative Protein Targets Derived from the SARS Genome," FEBS Letters 2003, 554, 257-263.
    • (2003) FEBS Letters , vol.554 , pp. 257-263
  • 3
    • 84555167792 scopus 로고    scopus 로고
    • Yue-Dan Wang,Wan-Yee Fion Sin, Guo- Bing Xu,Huang-Hua Yang,Tin-yau Wong,Xue-Wen Pang,Xiao-Yan He,Hua-Gang Zhang,Joice Na Lee Ng, Chak-Sum Samuel Cheng,Jing Ju,Li Meng,Rui-Feng Yang,Sik-To Lai Zhi-Hong Guo,Yong Xie, and Wei- Feng Chen1
    • T-Cell Epitopes in Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Protein Elicit a Species T-Cell Immune Response in Patients Who Recover from SARS. Yue-Dan Wang,Wan-Yee Fion Sin, Guo- Bing Xu,Huang-Hua Yang,Tin-yau Wong,Xue-Wen Pang,Xiao-Yan He,Hua-Gang Zhang,Joice Na Lee Ng, Chak-Sum Samuel Cheng,Jing Ju,Li Meng,Rui-Feng Yang,Sik-To Lai Zhi-Hong Guo,Yong Xie, and Wei- Feng Chen1.
    • T-Cell Epitopes In Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Protein Elicit a Species T-Cell Immune Response In Patients Who Recover From SARS
  • 4
    • 0036100230 scopus 로고    scopus 로고
    • Meningococcal disease: How to prevent and how to manage
    • SARS Vaccine Development
    • SARS Vaccine Development Shibo Jiang, Yuxian He, and Shuwen Liu Balmer, P. and Miller, E. (2002) Meningococcal disease: how to prevent and how to manage. Curr. Opin. Infect. Dis. 15, 275-281.
    • (2002) Curr. Opin. Infect. Dis , vol.15 , pp. 275-281
    • Jiang, S.1    He, Y.2    Shuwen, L.B.P.3    Miller, E.4
  • 13
    • 17144412605 scopus 로고    scopus 로고
    • Current status of anti-SARS agents
    • Shigeta S, Yamase T, Current status of anti-SARS agents. Antivir Chemother 2005; 16; 23-32.
    • (2005) Antivir Chemother , vol.16 , pp. 23-32
    • Shigeta, S.1    Yamase, T.2
  • 14
    • 55149099210 scopus 로고    scopus 로고
    • Long-term persistence of robust antibody and cytotoxic T cell responses in recovered patients infected with SARS coronavirus
    • Lit, et al. Long-term persistence of robust antibody and cytotoxic T cell responses in recovered patients infected with SARS coronavirus. PLoSONE. 2006; 1:e24.
    • (2006) PLoSONE , vol.1
    • Lit1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.